Navigation Links
ULURU Inc. Announces Conference Call To Discuss Financial Results For The Second Quarter Ended June 30, 2014 And To Provide A Business Update
Date:8/7/2014

ADDISON, Texas, Aug. 7, 2014 /PRNewswire/ -- ULURU Inc. (OTCQB: ULUR) today announced that it has scheduled a conference call to discuss the second quarter ending June 30, 2014 financial results and to provide a business update on August, 15, 2014 at 9:00 a.m. Eastern Time.

To participate in the conference call please dial (877) 387-2201, for international callers dial (850) 429-1388 (access code 24097#) five to ten minutes prior to the initiation of the teleconference.  If you are unable to listen to the live broadcast, a replay of the call will be available starting on August 15, 2014 two hours following the end of the call until August 29, 2014 at 11:59 p.m. Eastern Time.  For the U.S. replay, please dial (866) 415-9493 and international callers please dial (205) 289-3247 (access code 24097#).  You may also access the replay of the call two hours following the end of the call until August 29, 2014 at 11:59 p.m. Eastern Time via the web by logging onto http://replay.multipointcom.com.

About ULURU Inc.:ULURU Inc. is a specialty pharmaceutical company focused on the development of a portfolio of wound management and oral care products to provide patients and consumers with improved clinical outcomes through controlled delivery utilizing its innovative Nanoflex® Aggregate technology and OraDisc™ transmucosal delivery system. For more information about ULURU Inc., please visit www.uluruinc.com.  For more information about Altrazeal®, please visit www.Altrazeal.com.

This press release contains certain statements that are forward-looking within the meaning of Section 27a of the Securities Act of 1933, as amended. These statements are subject to numerous risks and uncertainties, including but not limited to the risk factors detailed in the Company's Annual Report on Form 10-K for the year ended December 31, 2013 and other reports filed by us with the Securities and Exchange Commission.Contact: Investor RelationsContact: CompanyJim MacDonald Kerry P. Gray Torrey Hills CapitalPresident & CEO (858) 456-7300 Terry K. Wallberg Vice President & CFO(214) 905-5145 

 

 


'/>"/>
SOURCE ULURU Inc.
Copyright©2014 PR Newswire.
All rights reserved

Related medicine technology :

1. ULURU Inc. Announces the Expansion of the International Marketing Network
2. ULURU Inc. Reports Third Quarter 2013 Financial Results
3. ULURU Inc. Announces Conference Call To Discuss Financial Results For The Third Quarter Ended September 30, 2013
4. ULURU Inc. Completes Redemption Of Preferred Stock
5. ULURU Inc. Reports Second Quarter 2013 Financial Results
6. ULURU Inc. Announces Conference Call To Discuss Financial Results For The Second Quarter Ended June 30, 2013
7. ULURU Inc. Reports First Quarter 2013 Financial Results
8. ULURU Inc. Announces Conference Call To Discuss Financial Results For The First Quarter Ended March 31, 2013
9. ULURU Inc. Reports Financial Results For Fourth Quarter And Year Ending December 31, 2012
10. ULURU Inc. Announces Conference Call to Discuss Financial Results for the Fourth Quarter and Year Ended December 31, 2012 and to Provide a Business Update
11. ULURU Inc. Business Update And Outlook
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/10/2017)... 10, 2017  The Corporate Whistleblower Center says, ... sleep therapy clinics to call us anytime at ... is involved in a substantial scheme to overbill ... from an employee of a medical equipment company ... to provide medical practice groups with extra generous incentives ...
(Date:5/9/2017)... , May 9, 2017  Oramed Pharmaceuticals ... ), a clinical-stage pharmaceutical company focused on the ... that the Canadian Intellectual Property Office has granted ... Oral Administration of Exenatide". The patent covers Oramed,s ... GLP-1 is an incretin hormone that ...
(Date:5/6/2017)... , May 5, 2017  May is Stroke ... one of the most important methods to prevent a ... the Centers for Disease Control and Prevention, undetected and ... 1 Omron, the global leader in personal heart ... the elimination of heart attack and stroke and is ...
Breaking Medicine Technology:
(Date:5/26/2017)... ... 26, 2017 , ... Amir Qureshi, MD is the first physician in Arkansas ... stimulation system. The Nuvectra™ Algovita SCS System has been FDA approved as a treatment ... in Arkansas to introduce the most powerful SCS system and the only stretchable lead ...
(Date:5/26/2017)... ... May 26, 2017 , ... On May 24, the ... narrowly passed the U.S. House on May 4, would result in 23 million Americans ... continued implementation of the 2010 Patient Protection and Affordable Care Act (ACA). , ...
(Date:5/26/2017)... ... May 26, 2017 , ... Dr. Alex Rabinovich, a ... announce a new, informational blog post on insurance options. If a Bay Area patient ... may help save time and money. Visiting an in-network provider for a second opinion ...
(Date:5/26/2017)... , ... May 26, 2017 , ... “Cactus Jack: Against ... on so many others. “Cactus Jack: Against All Odds” is the creation of ... Walter D. Hubbard is married to Jack Carlisle’s third child Jane. Walter. Walter ...
(Date:5/24/2017)... Hills, CA (PRWEB) , ... May 24, 2017 , ... ... announced today its participation in nVerge 2017 – a one-day technology conference in San ... Altec’s document management solution, which allows users to fully utilize and enhance their Sage ...
Breaking Medicine News(10 mins):